-----===[[[ A I D S w i r e D I G E S T 02.15.93 ]]]===----- U.S. Starts Initial Human Tests on New Type of AIDS Vaccine * Los Angeles Times (02.14.93), P. A7 On Friday, the federal government began preliminary human trials of an AIDS vaccine, which researchers hope will protect against several strains of HIV. The National Institute of Allergy and Infectious Diseases (NIAID) said researchers would first give the vaccine to 36 healthy volunteers to test its safety and the immune system response of the participants. The vaccine is manufactured by United Biomedical Inc. of Hauppauge, N.Y. It is a so-called "peptide vaccine," based on a laboratory-synthesized protein fragment, or peptide. An agency AIDS researcher, Margaret Johnston, said, "Peptide vaccines have two particular strengths: They are inexpensive and relatively easy to modify, to include new mixtures of peptides and those from different HIV strains." There are at least five genetically distinguishable strains of HIV, according to research. The NIAID said United Biomedical eventually wants to develop a vaccine involving a mix of peptides that would provide protection against all strains of the AIDS virus. A Place for Children Touched by AIDS * Washington Post (02.15.93), P. B3 Pressley, Sue Anne A facility designed to provide care for children affected by the AIDS epidemic will open in two weeks in Alexandria, Va. The PlayCare Center is the first childcare program of its kind in the Washington, D.C., area. The center will offer a free, safe place to leave young children for a few hours. Parents or guardians who have AIDS and need to see a doctor, go to the grocery store, or even take a nap can take advantage of the center's services. One HIV-positive woman said, "You find yourself needing a day for yourself. This disease is so stressful. It's nice to know I don't have to feel so overwhelmed." The PlayCare Center is sponsored by the Northern Virginia AIDS Ministry, known as NOVAM. The center is not a day-care program, but more like a special baby-sitting service, featuring volunteers from the Children's Hospital who are trained to deal with the sensitive problems of families coping with AIDS. NOVAM executive director Donald W. Leary said the program is not just for HIV-positive children, but also for all family members whose lives have been affected by the disease. The program has a $40,000 annual budget and will be offered in two small nursery classrooms at the United Methodist Church in Alexandria, Va. Initially, the center will be open only on Tuesdays, Wednesdays and Thursdays. Around the Region: Hunger Strike Threatened * Washington Post (02.16.93), P. E3 Jesse L. Jackson yesterday proposed organizing a hunger strike in the United States if the Clinton administration continues to refuse HIV positive Haitians admission into the country. After meeting with Chief of Staff Thomas F. "Mack" McLarty, Jackson, who started a personal hunger strike Sunday, said he supports President Clinton's policy on the Haitians but wants action within a week. Recently, Jackson returned from the Guantanamo Naval base in Cuba, where he joined HIV-positive Haitians in a hunger strike to prompt Clinton to lift the ban on their entry. A total of 267 Haitians are being detained at the base because their claims for political asylum have been refused due to their own or their family members' HIV-positive status. The majority of the Haitians are refusing their meals to some degree, but 15 or 20 are considered active strikers. Jackson said the expanded strike could involve "other leaders and other organizations that have been involved in the process." Last week, Clinton revealed that he wants to end the ban, which prohibits HIV-positive foreigners from entering the country. New Research Shows HIV and Cancer Genes May Be Blocked * United Press International (02.15.93) (Cleveland) A new drug may inhibit cancer and viral infections, including HIV, according to recent research conducted by the Cleveland Clinic and the National Institutes of Health, and published in the Monday issue of the Proceedings of the National Academy of Sciences. The drug, 2-5A-antisense, causes the breakdown of unwanted messenger RNA. Messenger RNA determines which protein will be made in the cell. Therefore, when the unwanted RNA is broken down, the gene cannot function. Dr. Robert Silverman of the Cleveland Clinic's Cancer Biology Department said, "The research is in its very early stages. But our results are exciting. This method takes a much more targeted approach to treating viral infections and cancer." The approach reported uses a modified "antisense," which is a piece of DNA that seeks out and binds with messenger RNA. Attached to the antisense is an enzyme activator, known as 2-5A. The antisense binds to the unwanted messenger RNA, which is then killed by the activated enzyme. The report states, "In any virus, the genes have a sequence unique in nature. In theory, we can make an antisense that will bind only to the virus RNA without binding to human RNA, thereby destroying the virus without harming the person." Silverman warns that the findings have been in cell extracts, not within animals or people. But he said the researchers still consider the results quite promising. Blood Program Lacks Expertise, Doctor Contends * Toronto Globe and Mail (02.12.93), P. A3 York, Geoffrey The Canadian Red Cross blood transfusion program is poorly organized, which has caused several top physicians to leave the organization, a former senior official has cautioned. Gail Rock, medical director at the Ottawa center of the Red Cross transfusion service from 1974 until her dismissal in 1988, said she is concerned about the lack of trained experts in the blood program. She told a House of Commons subcommittee on Thursday that the national office has only one full time physician, and he had no training in transfusion medicine before joining the Red Cross. But Rita Cloghesy, a Red Cross spokeswoman, said the blood program did not have a shortage of medical expertise. However, Dr. Rock argued that even after more than 1,000 Canadians contracted HIV from tainted blood products in the early 1980s, a senior official at the Red Cross refused to believe the medical proof that HIV could be transmitted through blood transfusions. She said that the Canadian Red Cross has also failed to make its citizens aware that they can donate their own blood for transfusions, a process that is much more common in the United States. Dr. Norbert Gilmore, a professor of medicine at McGill University and former chairman of the National Advisory Committee on AIDS, told the subcommittee there was a lack of coordination among several organizations and agencies that are involved in the Canadian blood transfusion system. He said this lack of coordination "may have disastrous consequences" if there is a rapidly spreading virus in the future. Hemophiliac Pleads for Redress * Toronto Globe and Mail (02.12.93), P. A3 Cox, Kevin A man who contracted HIV through a contaminated blood transfusion and is dying of AIDS made an appeal Thursday to provincial governments in Canada to compensate the families of those with the disease. Randy Conners said, "I think a great injustice has been done to me and my family and I want just compensation. I want to know that after I die my family doesn't have to lose our home or go on welfare." He also said he may only have a few months to live and is concerned about what will happen to his wife, Janet, who is also infected with HIV, and their 12-year-old son. A Canadian federal program has been giving the Conners family, in addition to about 1,000 other HIV-positive Canadians, a maximum of $120,000 over four years. That program will end on April 1. The provincial governments have recently refused to give compensation to these people, all of whom contracted HIV through infected blood products. The infected blood made its way into the blood supply in several countries before aggressive screening and lab testing was introduced in Canada in 1985. Mr. and Mrs. Conners, along with Dan Doran, president of the Nova Scotia Hemophilia Society, made their request for compensation for the families of people affected by the tainted-blood scandal to provincial Health Minister George Moody last week. John Sansom, a spokesman for the Health Department, said that Moody has decided to examine the situation with other provincial health officials to determine if a compensation package would be feasible. Bishop Urges Nationwide Fight Against Government Safe Sex Drive * United Press International (02.15.93) (Manila, Philippines) The archbishop of Manila is encouraging Roman Catholics nationwide to fight attempts by President Fidel Ramos' government to promote the use of condoms as a means of preventing the spread of HIV infection. Cardinal Jaime Sin asked Manila parishioners on Sunday in his sermon to "join hands" in the fight against abortion, condoms, and prostitution. The sermon was the most recent strike at the nation's first Protestant president. Ramos, a Methodist, has contradicted the church's beliefs by backing his health secretary's policy of distributing condoms to prevent HIV and educating people in the predominantly Catholic nation about all means of birth control. Sin said, "We all know how hard our lives are in the Philippines, but what I don't understand is why the government doesn't care for the feelings of Christians in our country." Many church leaders and conservative legislators demanded the resignation of health secretary Juan Flavier after the former country physician started distributing condoms in public early this year. The Catholic Bishops Conference called the use of condoms a "simplistic and evasive" solution to preventing HIV infection, according to a pastoral letter read in Catholic churches nationwide Feb. 7. The Department of Health reports that 368 Filipinos have been found to have AIDS. Flavier said Thursday that the actual number could be 100 times that figure. Newsline: Fear of AIDS Suit Allowed * National Law Journal (02.15.93) Vol. 15, No. 24, P. 17 A federal ruling permitting a worker to sue his employer for his fear of AIDS is believed to be the first of its kind. The decision was called a "landmark" by prominent AIDS plaintiffs' litigator David B. Baum of San Francisco's Baum, Wiss, & Blake. U.S. District Judge Arthur D. Spatt of the Eastern District of New York, ruled on Jan. 26 that a Long Island Rail Road (LIRR) employee who was accidentally stuck with a hypodermic needle while cleaning a railroad station can sue his employer for his fears that he became infected with HIV. Supermarket Video: AIDS Committee Sets Fund-Raiser to Start Nov. 24 * Supermarket News (02.08.93) Vol. 43, No. 6, P. 37 A multi-million dollar fundraising effort will be led by the Video Industry AIDS Action Committee between Nov. 24 and Dec. 1, 1993. The program, called "A Penny for AIDS," asks retailers to donate one cent to VIAAC for every video rental and sale. The campaign was announced during the Video Software Dealers Association Regional Leaders Conference in La Jolla, Calif. The fundraiser program will also request that suppliers donate one cent for every $2 of revenue during the period. Unexplained Opportunistic Infections and CD4+ T-Lymphocytopenia Without HIV Infection * New England Journal of Medicine (02.11.93) Vol. 328, No. 6, P. 373 Smith, Dawn K., et al. The mysterious AIDS-like condition without evidence of HIV infection that has recently been reported appears to be rare and not transmissible, write Dr. Dawn K. Smith and colleagues of the Centers for Disease Control in Atlanta, Ga. Researchers conducted investigations to determine the demographic, clinical, and immunologic features of patients with idiopathic CD4+ T lymphocytopenia (ICL); whether the syndrome is epidemic or transmissible; and its possible causes. The researchers reviewed 230,179 cases in the CDC AIDS Reporting System and performed interviews, medical reviews, and laboratory analyses of blood specimens from adults and adolescents who met the CDC definition of ICL. The patients' sexual contacts, household contacts, and persons who had donated blood to them were also tested. The researchers interviewed 31 of the 47 patients identified with ICL, as well as 23 of their contacts. A total of 18 patients had one or more risk factors for HIV infection: seven had hemophilia, six had engaged in homosexual sex, six had received blood transfusions, and two had had heterosexual sex partners who were at risk for HIV infection. The other 29 patients had no risk factors for HIV infection. When blood from 28 patients was tested, eight were found to have T-cell counts of less than 300 cells per cubic millimeter, and 6 had fewer than 250 T-cells per cubic millimeter. The researchers determined that 10 sex partners, three household contacts, and four children of the ICL patients, as well as six persons who had donated blood to the patients, were immunologically and clinically normal. Survey Finds a Third of Firms Have Policies on Workers With AIDS, HIV * Boston Globe (02.16.93), P. 43 Brudney, Juliet F. Approximately one-third of 535 mid-to-large-size companies surveyed nationwide have implemented anti-AIDS policies, according to The Wyatt Company, a human resources consulting firm. These programs included employee education, training for managers, one-to-one counseling, and referrals. Dr. John Bunker, a Wyatt consultant, said the policies usually condemn discrimination against people with HIV infection or AIDS, and state that reasonable accommodations will be made to help employees stay on the job as long as they can continue to perform essential functions. Moreover, confidentiality issues are discussed in most company policies. DAKA International, which owns restaurant chain Fuddruckers, was one of the companies surveyed. It requires all employees to attend a session on how HIV is contracted, and how to prevent it. Managers must attend half- to full-day training sessions that address company commitments, state and federal laws prohibiting discrimination and harassment of employees with AIDS or HIV, and the employer's obligation to provide reasonable accommodations. Also, an 800 information-and-referral telephone number is about to be established for internal use only. Polaroid is another company that provides an aggressive anti- AIDS program. It has considered prevention through education its major goal since its AIDS program was launched in 1987. In addition to educating employees, Polaroid has an information office equipped with multi-media materials that offers education sessions for employees' families and friends. The corporation and Polaroid Foundation fund home care, peer-led support groups, and other direct services. Chronicle: Randy Shilts, Whose Best-Seller About AIDS is Headed for HBO, Says He Has the Disease * New York Times (02.17.93), P. B4 Randy Shilts, the author of the book "And the Band Played On," yesterday revealed that he has AIDS. The best-selling book discussed the progression of AIDS from an obscure and largely ignored condition to a nationwide epidemic. Shilts disclosed his condition in an interview conducted late last week and printed yesterday in The San Francisco Chronicle. Shilts said he learned of his HIV-positive status in 1985, "on the day that I pulled the last sheet from the typewriter of 'And the Band Played On.'" Shilts said that he decided not to reveal his condition publicly until now because he was afraid that it might diminish the effectiveness of his reporting for The San Francisco Chronicle. "Every gay writer who tests positive ends up being an AIDS activist, and I didn't want to end up being an activist. I wanted to keep on being a reporter." Shilts has recently completed his third book, "Conduct Unbecoming: Gays and Lesbians in the Military." As he was nearing completion of the book, he suffered a collapsed lung that forced him to stop writing. Friends and associates helped him finish it. Currently, he is recuperating and in physical therapy and an undisclosed location. A television version of "And the Band Played On" will be aired on HBO in late summer, and is expected to involve several celebrity actors. Effort to Manufacture Artificial Blood is Thwarted * Los Angeles Times--Washington Edition (02.17.93), P. B7 Maugh, Thomas H. The production of an artificial blood product has encountered an unexpected hindrance that may seriously postpone its commercialization, said a University of California--San Diego physician at a meeting of the American Association for the Advancement of Science. While researchers from the four companies conducting clinical trials on the artificial bloods have not disclosed the preliminary findings from their trials, enough information has been released to allow observers to figure out the cause of the difficulties, said Dr. Robert M. Winslow, a professor of medicine at UC-San Diego who was formerly in charge of the U.S. Army's efforts to develop an artificial blood. Participants in the clinical trials of the artificial bloods have reported various unexpected side effects, including chest pains, back pains, nausea, and hypertension. What seems to be the cause is nitric oxide (NO), which interacts with artificial blood, Winslow said. The hemoglobin in the artificial blood is leaking out of blood vessels and into the surrounding tissues, where it binds NO tightly, inhibiting its vasorelaxant properties, said Winslow. Consequently, the blood vessels constrict, causing the unusual symptoms. The problem could be very hard to solve because NO binds with the hemoglobin at the same molecular location that oxygen does. Any efforts to prevent the binding will most likely restrict hemoglobin's oxygen-carrying capacity. People and Places: Belgium Launches Condom Campaign * Baltimore Sun (02.17.93), P. 2A The condom is being strongly promoted in an anti-AIDS advertising campaign in Belgium, a predominantly Roman Catholic country. Social Affairs Minister Leona Detiege said that Belgians use condoms less than half as often as other Europeans. The condom was prohibited in Belgium until 1973, and advertising was under strict regulation until 1984. The new promotional campaign, called "Zet 'm Op"--which means both "put it on" and "go for it" in Dutch--will be featured in advertising on radio, television, and in cinemas. Senate Tackles AIDS Controversy * United Press International (02.17.93) Gerstel, Stev (Washington) Senate Republicans have waged a major debate with President Clinton over his campaign pledge to eliminate the ban that prohibits HIV-foreigners from entering the United States. Senate Republican leader Robert Dole said Tuesday he would introduce an amendment to legislation re-authorizing the National Institutes of Health that would make the anti- immigration policy a law. However, Clinton had not signed the executive order to lift the ban. Health and Human Services Secretary Donna Shalala said it is still being reviewed, and Dole did not offer his amendment. But Dole's top deputy, Sen. Alan Simpson (R-Wyo.) said the proposal to lift the ban calls into question two things--are HIV-positive immigrants "a public health risk" and "do they become a public charge." Sen. Simpson said these questions and others call for thorough study before consideration is given to lifting the ban, and added that too frequently "we do something out of emotion, fear, guilt, yes, racism -and it's not always the right thing." Simpson said that among the 45,000 immigrants allowed into the United States, 20 percent are infected with HIV. The immigrants he spoke of are thought to be from Haiti, but Simpson did not specify. He said the United States should continue the ban but provide waivers for family reasons and enable those with AIDS to participate in conferences held in the United States. Among the 267 Haitians held at Guantanamo Bay, Cuba, 215 are infected with HIV; the others are their spouses and children. Of those Haitians, 10 have full-blown AIDS. Princess of Wales Attacks Britain for AIDS Prejudice * United Press International (02.16.93) (London) Princess Diana of Wales told a London conference on AIDS Tuesday that fear and ignorance were the cause of the alienation of people with HIV or AIDS in Britain. She spoke of the social problems, prejudice, intolerance, and British reluctance that isolated AIDS patients from their families. "All too soon we all will know someone with AIDS.... How will we treat them? With compassion and care, or fear and rejection?" she asked. The princess told of the loneliness and isolation people with AIDS experience and described her meeting with one woman dying of the disease who had been rejected by her family. "Her wasted hand reached out for help. She'd been abandoned by her family, who saw her as an unbearable embarrassment and disgrace," said Diana. She added, "Still I am meeting patients like her, rejected by family and past friends, leaving them with the fear of not being able to find someone to share their emotional overload and physical disablement and ultimately their death." The princess called for British people to eliminate the barriers and overcome the prejudice and abandonment they inflict on people with AIDS. Ashe-AIDS Endowment * Associated Press (02.13.93) (Memphis, TN) A pediatric AIDS research endowment of $1.25 million named for tennis legend Arthur Ashe will be given to St. Jude Children's Research Hospital. The announcement came during the Kroger-St. Jude International tennis tournament on Saturday. J. Wayne Richmond, executive vice president of the IBM-ATP Tour, said, "One call to Arthur and he was quickly on board. He worked up to 48 hours before his death to make this happen." IBM-ATP was previously called the Association of Tennis Professionals. The Racquet Club of Memphis, site of the tournament, Kroger, and the IBM-ATP Tour Charities are involved in raising the money for the $1.25 million contribution. Ashe recorded a videotape about the effort days before his death. St. Jude is part of the AIDS Clinical Trials Group--a network of 24 pediatric and 28 adult AIDS research units nationwide. Fearful of AIDS, China Lifts Veil on Homosexuality * United Press International (02.17.93) Leicester, John (Beijing) Although the Chinese government previously denied that homosexuality existed and jailed anyone suspected of being gay, the AIDS epidemic has forced officials to try to lure them back. Officials at the National Health Education Institute in China established "Men's World," a support group for gay men, last year. The authorities hoped that Chinese homosexuals could be educated about the risks of HIV infection before it devastates gay communities as it has in the West. Currently, only 3 of the 969 reported cases of HIV infection have been among gay men, but health officials claim these figures are misleading. Wan Yanhai, an official at the institute and a pioneer in AIDS prevention work among gay men, said, "I think in reality the number could be much higher, [and] it is definitely going to rise." In 1991, a study was conducted among homosexuals which found that just 3.9 percent "knew a lot" about AIDS. But most believed AIDS posed no risk and only 6 percent had ever used condoms, even though they may have had hundreds of sex partners. What was more alarming was that 25 percent of the 96 men surveyed were found to have a sexually transmitted disease, which increases the chance of HIV transmission. "Men's World" plans on implementing a gay counseling hotline and center in Beijing and AIDS hotlines in Shanghai and Canton, distributing condoms and training gay men as educators who would use their knowledge of China's secretive gay communities to instruct on HIV prevention. Idiopathic CD4+ T-Lymphocytopenia--Immunodeficiency Without Evidence of HIV Infection * New England Journal of Medicine (02.16.93) Vol. 328, No. 6, P. 380 Ho, David D. et al. It remains undetermined whether idiopathic CD4 T- lymphocytopenia (ICL) is new, transmissible, or acquired, write David D. Ho et al. of the Aaron Diamond AIDS Research Center in New York, N.Y. Patients recently diagnosed with severe CD4 T- lymphocytopenia but without evidence of HIV infection have spurred a national surveillance network to investigate such cases. The researchers examined 12 patients with CD4 T- lymphocytopenia who were referred by three U.S. cities. The patients (10 men and 2 women) ranged in age from 30 to 69 years. A total of eight had risk factors for HIV infection. The clinical conditions were heterogeneous: five patients had opportunistic infections, five had syndromes of unknown cause, and two had no symptoms. Two patients died from severe complications of their immunodeficiency. The patients' lowest CD4 T-lymphocyte counts ranged from three to 308 per cubic millimeter. Three patients had complete or partial spontaneous reversal of the CD4 T lymphocytopenia. Concomitant CD8 T- lymphocytopenia was found in three patientsJand abnormal immunoglobulin levels were found in five. Multiple virologic studies by serologic testing, culture, and polymerase chain reaction were completely negative for HIV in all patients. The researchers found that the 12 patients with ICL appear to be epidemiologically, clinically, and immunologically heterogeneous. Although the conditions experienced in the ICL patients resemble AIDS, HIV infection was not detected. The cause of ICL is unknown, the researchers conclude. Projections of the Number of Persons Diagnosed With AIDS and the Number of Immunosuppressed HIV-Infected Persons- United States, 1992-1994 * Journal of the American Medical Association (02.10.93) Vol. 269, No. 6, P. 733 The Centers for Disease Control recently released new estimates of the number of persons in the United States who will initially be diagnosed with an illness included in the 1987 AIDS surveillance case definition during 1992-1994. About 58,000 Americans had AIDS during 1991 as defined by the 1987 AIDS definition. Between 1992-1994, the number of persons who have illnesses meeting these criteria is expected to rise by only a few percent annually, with about 85 percent of those persons being reported to the CDC with cases of AIDS. The rate of increase in reported AIDS cases in persons who contracted HIV via heterosexual contact is expected to be higher than that in persons who contracted the virus through homosexual/bisexual contact or IV-drug use. The CDC predicts that, as of January 1993, an additional 120,000 to 190,000 Americans had HIV- related severe immunosuppression. Not all of these persons were aware of their HIV infection, however, and of those who know their HIV infection status, not all have had a T-cell count. If the AIDS definition went unchanged, about 50,000 to 60,000 reported AIDS cases would have been expected in 1993. The new definition of AIDS that includes HIV related severe immunosuppression should increase reported cases by about 75 percent. The effect of this expansion on the number of reported cases is estimated to be smaller in later years because in 1993 many prevalent as well as incident cases of immunosuppression will be reported as the expanded surveillance case definition is used. Reported AIDS cases may decrease from 1993 through 1994, according to the CDC. Multicenter Clinical Trials of AIDS Vaccines Scheduled to Get Under Way in Coming Months * Journal of the American Medical Association (02.10.93) Vol. 269, No. 6, P. 725 Marwick, Charles HIV-negative volunteers at high risk of infection areJbeing recruited for nationwide clinical trials of two AIDS vaccines. A total of about 320 male and female volunteers aged 18-60 years old will be involved. However, some officials from the National Institutes of Health project that it will be at least two more years before full-scale vaccine trials are conducted. The two vaccines will be tested in five American centers: Johns Hopkins University Center for Immunization, Baltimore, Md.; St. Louis (Mo.) University School of Medicine; University of Rochester (N.Y.) Medical Center; Vanderbilt University Medical Center, Nashville, Tenn.; and the University of Washington School of Medicine in Seattle. The two vaccines have already undergone safety testing, and do not appear to produce unwanted side effects. The trials will test the ability of two recombinant proteins made from the HIV envelope protein gp160 to boost protective antibodies and possibly cytotoxic T- lymphocyte responses, says Daniel Hoth, MD, director of the AIDS division at the National Institute of Allergy and Infectious Diseases. Volunteers will be counseled to avoid high-risk behaviors linked with HIV transmission. They will be assigned randomly to receive one of the vaccines or a placebo. Three intramuscular injections will be given--an initial injection and then two boosters at one and six months. One vaccine, genetically engineered by Genentech Inc., uses the HIV-1 MN strain. The other, made by Biocine, uses the closely related HIV-1 SF-2 strain. The two vaccines are equipped with adjuvants to further potentiate an immune response. TB Control Guidelines Cause Coast-to-Coast Confusion * American Medical News (02.08.93) Vol. 36, No. 6, P. 1 Voelker, Rebecca Due to the lack of a national plan to prevent tuberculosis transmission, federal, state, and regional health officials have developed conflicting respiratory-protection guidelines. The suggested measures range from protective surgical masks to the cumbersome powered air respirators proposed last year by the National Institute for Occupational Safety and Health. But in its current draft guidelines, the Centers for Disease Control backs away from the NIOSH-recommended respirators because of opposition from both health professionals and hospital administrators. Despite the tighter facial fit of the respirators, the CDC says, "There is not sufficient scientific evidence to support" their routine use. The agency instead suggests that protective surgical masks and valveless dust and mist respirators are sufficient for minimum protection. CDC spokeswoman Kay Golan said, "NIOSH was required by law to assess the risk and make recommendations so that no worker suffers. They were prohibited from considering cost or feasibility when they made their recommendations." But if the NIOSH recommendations are adopted in a federal OSHA standard, they could become legally enforceable. Dr. Michael Tapper, chairman of the AIDS/TB committee of the Society for the Hospital Epidemiologists of America, attended a meeting at the CDC in Atlanta concerning its first round of revisions to the 1990 guidelines for TB control in health-care settings. He said that consensus based on science is desperately needed to dispel the confusion. Drug Combination Stops AIDS Virus Reproduction * Washington Post (02.18.93), P. A3 A drug strategy has been developed that inhibits HIV from reproducing in a test tube, according to a report published in Thursday's issue of Nature by researchers from the Massachusetts General Hospital and the Harvard Medical School in Boston. The technique involves a combination of three drugs: AZT, ddI, and a third compound called pyridinone. All three drugs attack a single enzyme, called reverse transcriptase, which HIV needs to reproduce. If the approach is found to also block the spread of HIV in people, a patient's immune system might be able "to at least keep the virus in control for long periods of time, and perhaps forever," said Martin Hirsh, one of the researchers in the study. However, he and other researchers warn that it will take experiments in humans to determine if the technique is actually effective. HIV can mutate to produce subtle alterations in the enzyme that yield resistance to individual drugs. Yung-Kang Chow, one of the researchers, said the concept behind the "convergent combination therapy" was that the virus would be unable to resist a triple attack. In addition, thwarting the spread of the enzyme might prevent the virus from developing drug- resistant strains, said Chow. The researchers infected blood cells with HIV, then waited a week until HIV reproduction was at its peak. At this point, they added the three-drug combination. After 35 days, the infection was no longer detectable. After 49 days of treatment the drugs were discontinued, and no HIV reproduction was evident for the next 45 days. The three drug combination will be tested in a study of people with advanced stage HIV infection beginning this spring. Related Stories: New York Times (02.18) P. A1: Philadelphia Inquirer (02.18) P. A3 New York Needle Exchanges Called Surprisingly Effective * New York Times (02.18.93), P. A1 Navarro, Mireya The New York city needle exchange program designed to curb the spread of HIV among drug addicts has attracted substantial numbers of IV drug users and convinced several of them to share their used needles less frequently, according to experts evaluating the effort. The programs, which began six months ago, have enrolled 5,000 IV-drug users, far more than previous needle swap efforts in the city, both legal and illegal. Also, the programs have not led to increased drug use among the addicts. The program results are significant because of the city's estimated 200,000 IV-drug users, 50 percent are infected with HIV. Dr. Don C. Des Jarlais, director of research for Beth Israel Medical Center's Chemical Dependency Institute, said that the early findings are parallel to those from Europe, Canada, and other cities in the United States, including Tacoma, Wash., and Portland, Ore. The city began four new pilot programs between July and November of last year, which were funded with money from the American Foundation for AIDS Research, and the New York State Department of Health. Unlike an earlier program, the new ones are operated by community groups already experienced in working with drug users. Those participants interviewed said they were sharing their needles less: 20 percent said they still borrowed syringe needles from others, compared with 30 percent before the programs; and 10 percent said they rented or bought used needles, compared with more than 25 percent earlier. The programs have received little resistance from the community, and have been successful in linking the addicts with health care and housing, according to evaluators. At a Base in Cuba, Many Haitians Live in Doubt With HIV * Philadelphia Inquirer (02.18.93), P. A13 Viglucci, Andres A significant number of the HIV-positive Haitians held at the Guantanamo Bay Naval Base in Cuba who are participating in a hunger strike are also refusing to take medications that could slow disease progression. For some of the Haitians, the reluctance is an act of defiance or hopelessness, but most don't even believe they are infected with HIV. A few are so suspicious that they believe the drugs they are given are poison, according to independent physicians who visited the camp last week. There is no exact count of the Haitians refusing medication. However, physicians fear that a notable number of the 267 men, women, and children at the base are taking the drugs only sporadically, or not at all. Dr. Jean Ford, a Columbia University Medical School professor who recently spent five days at the base, said, "My sense was that at least half, and as many as two thirds, are not taking the medication the way they're supposed to." Navy physicians who operate the camp clinic say they have been frustrated by the refugees' reluctance to take the treatments since long before the three-week-old hunger strike. Now, the doctors are so busy dealing with fainting or dehydrated refugees that they are unable to monitor the development of the patients' HIV infection as closely as before. Doctors are also concerned about what the hunger strike might do the already-depleted immune systems of many refugees. Two Haitians recently suffered a recurrence of tuberculosis infection, which Navy doctors had managed to control months ago only after threatening isolation for those who refused to take medication. TB Drugs * Associated Press (02.16.93) Johnson, Linda A. (Trenton, NJ) Responding to a resurgence of tuberculosis cases that resist therapy, federal health officials are reintroducing three drugs that pharmaceutical firms stopped marketing. Bristol-Myers Squibb will introduce the first anti-microbial drug, its injectable form of isoniazid, which should be on the market within 10 days. The FDA asked the pharmaceutical manufacturers to resume production of the three tuberculosis drugs because of the public health threat that tuberculosis now poses. The companies stopped selling the drugs in 1990, because they were not producing profits. Inmate With H.I.V. Who Bit Guard Loses Appeal * New York Times (02.18.93), P. B7 Sullivan, Joseph F. A Trenton, N.J., appeals court yesterday upheld the attempted murder conviction of an HIV-positive prisoner who bit a prison guard. The court said it was irrelevant whether actually biting someone could transmit HIV, as long as the infected prisoner believed it could. The decision by the Appellate Division of the Superior Court confirmed part of the jury instruction given by the trial judge, John B. Mariano of Superior Court, who said, "Impossibility is not a defense to the charge of attempted murder. That is because our law, our criminal statutes punish conduct based on state of mind. It punishes purposeful actions regardless of whether the result can be accomplished." Judge Mariano added that this would hold true "even if the result, which in this case would be death, was a scientific or factual impossibility." The prisoner's conviction added 25 years to his earlier robbery sentence of five years; he was sent to Trenton State Prison from Camden County Jail. The inmate's attorneys, Ronald L. Kuby and William M. Kunstler of the Center for Constitutional Rights, said they would appeal yesterday's decision to the New Jersey Supreme Court. The lawyers said the appeals court was surrendering to "AIDS hysteria," and added that the ruling not only affects the prisoner, but "is a tragedy for the hundreds of thousands of HIV positive people who will continue to face irrational discrimination at the hands of the ignorant and fearful." The prisoner, Gregory Dean Smith, bit the prison guard on June 11, 1989, saying, "Now die, you pig! Die from what I have!" In the News: Increased Funding Sought for Anacostia AIDS Clinics * Washington Post (02.18.93), P. D.C. 1 The executive director of Washington, D.C.'s Whitman-Walker Clinic requested more money for AIDS services east of the Anacostia River. Jim Graham testified Tuesday before the D.C. Council's Committee on Human Services and called for an additional $1 million. He said approximately 20 percent of the District's AIDS patients live east of the Anacostia River, but that area has only two of the city's 19 primary care facilities for people infected with HIV. Also, both clinics can only treat a limited number of people. Graham said, "We must change the geographic balance of AIDS services in this city to reflect the realities of the epidemic. We must end AIDS medical apartheid for people with HIV east of the Anacostia River." Media Notes: Is Being Positive a Negative on the AIDS Beat? * Washington Post (02.18.93), P. C1 Kurtz, Howard The disclosure of author/reporter Randy Shilts' HIV-positive status has brought into question whether he can still be objective when writing about the AIDS-related issues. Shilts, a San Francisco Chronicle reporter, is openly gay. However, he did not disclose his HIV-positive status until recently, even though he knew of his condition in 1987 before he published his book, "And the Band Played On." The book details the emergence of the AIDS epidemic. Shilts said, "Every gay writer who tests positive ends up being an AIDS activist, and I didn't want to end up being an activist." The issue has confused minority journalists who find themselves dealing with questions about their "objectivity." Chronicle Editor William German said he did not wish to publicize Shilts' condition until Shilts chose to do so himself. German said, "If we thought of eliminating reporters who might not be objective because of their ancestry or their politics, frankly, we'd go out of our minds and it would be impossible to practice journalism." But Jeffrey Schmalz, a New York Times reporter who has spoken and written about having AIDS, said that "everyone knew Randy was gay. I don't agree with the argument it would have compromised him." He added, "When I write about AIDS the objections come not from the right but from people in the gay community who call me and say: 'You're not out front enough on this issue.... My response is, I'm a reporter first." Victor Zonana of the Los Angeles Times said that "illness is a private matter," and that even editors have no right to learn of an employee's HIV-positive status. News Digest: Sanction for Nureyev's Doctor? * American Medical News (02.08.93) Vol. 36, No. 6, P. 2 A French medical watchdog group claims it may take action against Rudolph Nureyev's doctor for disclosing details of the renowned dancer's fight with AIDS. Without naming either Nureyev or his physician, Dr. Michael Canesi, the Order of Doctors' board of directors said it was "indignant about statements by a doctor about the illness and circumstances of the death of a great artist." Nureyev died Jan. 6. The Order of Doctors can suspend or revoke Dr. Canesi's license. Food for Life * American Medical News (02.08.93) Vol. 36, No. 6, P. 31 The Physicians Association for AIDS Care wants doctors who care for HIV/AIDS patients to treat nutrition as if it were a form of pharmacology. PAAC has implemented a new effort to streamline doctors' work in assessing, monitoring, and treating HIV-related malnutrition. What makes this possible is a computerized algorithm that provides updated nutrition information. Also, doctors can have their patient's diets examined and reviewed by a registered dietitian. HIV/AIDS patients can receive individualized treatment plans, and the dietitian is available via a toll-free number. In addition, the PAAC has released proceedings from its First International Symposium on Nutrition on HIV/AIDS, held last summer at the Eighth International Conference on AIDS. AIDS and the Law * American Medical News (02.08.93) Vol. 36, No. 6, P. 31 A doctor who contracted HIV via a needlestick during her first month as an intern has sued the medical-equipment company Beckton Dickinson and Co. for $1.1 billion. The doctor said she was pricked while recapping a hypodermic needle after drawing blood from an AIDS patient. She said the needle was "grossly defective" because it wasn't created to prevent needlesticks upon disposal. The incident happened in 1986, before the Centers for Disease Control released universal guidelines that prohibit recapping needles. A Beckton Dickinson attorney said that the incident was unfortunate, but the firm did not consider itself responsible. Dossier: Something Old, Something New * Advocate (02.09.93) No. 622, P. 10 The sexual activity with the highest risk is anal sex, regardless of homosexual or heterosexual origin, and oral sex is a very low risk activity. Although this information has been known by the homosexual community for years, it took 12 years into the epidemic for the New York State health officials to release such information for the first time. Federal health officials still have not issued safer-sex guidelines. Joan Cleary, AIDS research coordinator for the state health department in Albany and author of the report, said, "We're not claiming this information is new, it's just a comprehensive review. Rarely do you ever see it backed up by scientific research. But the federal CDC has never been able to release this sort of information because of political pressure." Senate, 76-23, Votes to Bar HIV-Infected Immigrants * Washington Post (02.19.93), P. A2 Dewar, Helen The Senate voted yesterday to keep the ban preventing HIV- positive foreigners from entering the United States. The immigration ban was endorsed in a 76-23 vote and added to a reauthorization bill for the National Institutes of Health, which was subsequently passed and sent to the House by a vote of 93 to 4. President Clinton vowed to lift the immigration ban during his campaign, and a White House spokesman said earlier this month that Clinton advised the Department of Health and Human Services to remove the restriction. But 34 Democrats helped the Republicans led by Sen. Don Nickles (R-Okla.) succeed in writing the ban into permanent law, in effect preventing the president's plan to repeal it by executive order. The Democratic-controlled Senate chose the GOP proposal over a more moderate alternative drafted by Democratic leaders that would have delayed imposition of the new policy for 90 days. Although Democrats have hindered a vote on a similar bill in the House, Republicans restored their efforts yesterday on the proposal, arguing that it would pass. The NIH reauthorization bill would also give NIH's Office of AIDS Research (OAR) extensive power to direct government-funded research on HIV infection. Rather than going directly to the 21 institutes, the NIH money--about $1.1 billion this year--would pass through OAR. The director of the OAR would be an "AIDS czar" and would be responsible for developing a "strategic plan" for AIDS research. While many AIDS activists applaud the change, several scientists fear a more powerful OAR will add another layer of bureaucracy to NIH. Related Stories: New York Times (02.19) P. A11; Los Angeles Times- Washington Edition (02.19) P. A1; Baltimore Sun (02.19) P. 3A; Philadelphia Inquirer (02.19) P. A2; USA Today (02.19) P. 9A Reasons for HIV Exclusion * Washington Post (02.19.93), P. A21 Simpson, Alan Until it is resolved whether HIV-positive foreigners attempting to enter the United States are a public health risk and likely to become a public charge, the legislation passed yesterday prohibiting such people from immigrating will hold, writes Sen. Alan Simpson (R-Wyo.). The Clinton administration promised to lift the ban against HIV positive foreigners entering the United States, but that measure was defeated yesterday in the Senate. There was an influx of constituent calls and a stream of faxes to Capitol Hill offices over the matter. The legislation does allow waivers for visitors who come to see relatives, seek medical treatment, attend conferences, or have other short-term purposes. Also, there has always been a waiver for immigrants who come to join close family members living in the United States. AIDS is definitely a serious malady that threatens public health in America, as it does elsewhere in the world, says Simpson. About 175,000 Americans have died of the disease, and about 1 million to 1.5 million are estimated to be HIV-positive. The disease can result in medical expenses of $100,000 or more for each patient, according to recent predictions. It also appears that many HIV positive foreigners may soon become "public charges" after their admission to the United States, so the American Medical Association has therefore opposed the admission of such persons into the United States as permanent immigrants. When it can be determined whether or not these persons will be "public charges," then HIV infection should be taken off the list of communicable disease that are of public health significance, concludes Simpson. The Ban Makes No Sense * Washington Post (02.19.93), P. A21 Wiley, Dinah and Fornaci, Philip The Senate's approval yesterday of legislation that will continue to prohibit HIV-positive foreigners from being admitted into the United States was irrational and not based on scientific fact, write Dinah Wiley and Philip Fornaci of the Whitman-Walker AIDS Clinic in Washington, D.C. When the decision was initiated to ban people infected with HIV from entering the United States or from obtaining "green card" status in 1987, it was done not by medical authorities, but by right-wing Sen. Jesse Helms (R-N.C.), the authors write. The Senate's decision yesterday was "a shameful display of ignorance and prejudice." On June 1, 1991, Health and Human Services Secretary Louis Sullivan announced that HIV would be taken off the list of "communicable diseases of public health significance." But after political pressure from the White House, Sullivan was forced to reverse his position, and the exclusion for people with HIV remained intact. At the Whitman- Walker Clinic, many foreign-born HIV-positive people are assisted. These people are mainly immigrants already living here who are seeking permanent residency status. Even though many of these immigrants have lived, worked, and paid taxes in the country for many years, they are denied their green cards. Proponents of the ban contend that HIV-positive people will pose a burden on the already-strained U.S. health care system. However, people with cancer, hepatitis, or heart disease are not excluded from entering the country. It is clear that the Senate's decision is purely an act of discrimination against HIV-positive people, conclude the authors. In the Nation: Judge Scales Back Johnson AIDS Suit * Baltimore Sun (02.19.93), P. 9A Part of a lawsuit filed against basketball star Magic Johnson by a woman who alleged he infected her with HIV was dismissed yesterday by a federal judge. The $2 million lawsuit claimed that Johnson either was aware that he was infected with HIV or should have told the woman that he was at high risk for infection when the two had sex in June of 1990. U.S. District Judge Richard A. Enslen dismissed a count alleging that Johnson committed fraud by neglecting to tell the woman that "he had engaged in a sexually active, promiscuous lifestyle that put him at a high risk for becoming infected with the HIV virus." The other count that was dismissed said Johnson was "strictly liable for transmitting the HIV virus to [the woman] because of his abnormally dangerous and ultrahazardous activities." Woman Charged With Poisoning After Lover Gets AIDS * Reuters (02.18.93) Bon, Gerard (Paris) An HIV-positive French woman has been indicted for poisoning her boyfriend because she neglected to disclose her condition to him. An examining magistrate in the northeastern city of Metz charged the woman on Wednesday after her 29-year- old boyfriend filed a lawsuit alleging she knowingly infected him with HIV during their three-year relationship. The prosecutors would have to prove the woman, whose name has not been disclosed, meant to kill the man, known only as Fabien, according to attorneys. Health Minister Bernard Kouchner said, "Legal proceedings are not the right way to handle matters of public health and personal anguish." However, he added that people must be more open about their conditions. Fabien's attorney, Marie Laurence Fromer, contended that a need to encourage HIV-positive individuals to be candid was exactly what spurred the complaint. She said, "My client is not in any way motivated by revenge. He just wants to say to people who are HIV-positive that they should let their partners know." The poisoning charge will be studied further before determining whether to put the woman on trial. Attorneys said they may switch to a lesser charge of failing to help a person in danger. AIDS It Ain't: A Frightening Immune Disorder Turns Out to Be Rare and Noncontagious * Time (02.22.93) Vol. 141, No. 8, P. 21 The mysterious AIDS-like condition that was reported last summer at the Eighth International Conference on AIDS in Amsterdam does not appear to be infectious, according to reports in the New England Journal of Medicine. Researchers had reported patients who had alarmingly low levels of CD4 cells but no detectable evidence of HIV infection. Some likely causes of the disease include bacteria, fungi, and other parasites, poisons, and environmental toxins. Also, viruses may be involved, but not necessarily a single virus or even a family of them. In an accompanying editorial, Dr. Anthony Fauci, chief of U.S. AIDS research, said that last year's press speculation about a new AIDS virus was part of a "media frenzy" that was "inappropriate." Database * U.S. News & World Report (02.22.93) Vol. 114, No. 7, P. 8 AIDS ranks ninth for the cause of death among children aged 1 to 4 years old, and by the year 2000, AIDS could be the fifth leading cause of death of such children. In 1992, there were a total of 4,249 children under the age of 13 with AIDS, and a total of 2,267 children who have died from the disease. In addition, there are 1,800 HIV positive infants born each year in the United States. Approximately 10 million children worldwide will be infected with HIV by the year 2000, and by the end of the decade a total of 5-10 million babies will be born infected with HIV. Moreover, the projected number of children who will have been left orphaned by the AIDS epidemic by the year 2000 will reach 82,000. About 87 percent of Americans say they support educating children about AIDS and sexually transmitted diseases in early grades. Opening the Border to AIDS * Time (02.22.93) Vol. 141, No. 8, P. 45 Gorman, Christine The HIV-positive Haitian refugees held at the Guantanamo Bay, Cuba, Naval Base are the most visible symbol of what may become the next controversy to emerge between the Clinton administration and Congress. The Bush administration ruled the refugees had plausible claims for political asylum last year after they fled their country. Yet because most of them tested HIV-positive, they are prohibited from entering the U.S. Now they are waging a hunger strike in protest over the policy, even though President Clinton announced last week that he plans on eliminating the ban. Most of the medical community supports the president. Dr. June Osborn, chair of the National Commission on AIDS, said, "This shouldn't be a hot-button issue, especially when you consider the lack of a public health threat." But Senate Minority Leader Robert Dole wrote in a letter to Health and Human Services Secretary Donna Shalala last week, "Unless you believe we have the AIDS crisis under control, I would advise you to resist this potentially explosive policy change." If the administration removes AIDS from the list of communicable diseases barring entry, the National Commission on AIDS predicts that between 300-600 people with HIV/AIDS might immigrate into the country every year. A 1991 report by the commission states that HIV-positive individuals typically remain employed and self-sufficient for 10 years or more from the time of infection to development of full-blown AIDS. The report said, "Their economic contribution to our society will far outweigh the estimated lifetime cost of treating HIV-infected individuals." Still, Congress may make it difficult for Clinton to lift the ban. Federal Grants Cut Back * Advocate (02.09.93) No. 622, P. 19 Federal AIDS prevention funds have been cut just as the Centers for Disease Control has implemented its new definition of the disease that is expected to double the amount of people considered to have AIDS. CDC spokesman Kent Taylor said the drop in the total amount of funds granted to states for HIV prevention programs happened because Congress ordered funds diverted to other programs when it approved the CDC's 1993 budget. To compensate for the shifts, CDC officials had to shuffle the budget to provide $143.7 million in new funds for programs, up 1.5 percent from the $141.5 million in new funds the CDC provided in 1992. However, the rearrangement resulted in less money for states because there was less money remaining from 1992 expenditures than there was in 1991. By the end of 1991, agencies had about $20 million left to spend in 1992. But at the end of 1992, there was only about $15 million remaining. Therefore, in 1993 the CDC will allot state and local governments a total of about $155 million for AIDS prevention programs--down about 4.3 percent from $162 million given in 1992. States will feel the hardest impact--with about 5 percent less money available to them overall. Alan R. Hinman, director of the CDC's national center for prevention services, in a letter to state and local HIV project directors, said, "Almost all states will receive reduced levels of funding in 1993. No state will receive an increase in funds." Consequently, Arizona health department AIDS office director Doug Hirano said, "You've got more people who want to find out their HIV status at the same time the CDC is cutting the moneys we use to counsel and test people." Idiopathic CD4+ T-Lymphocytopenia--An Analysis of Five Patients With Unexplained Opportunistic Infections * New England Journal of Medicine (02.11.93) Vol. 328, No. 6, P. 386 Spira, Thomas J. et al. Because major differences were discovered in clinical, virologic, and immunologic findings between five patients with idiopathic CD4+ T lymphocytopenia (ICL), additional research is warranted, write Thomas J. Spira et al. of the Centers for Disease Control in Atlanta, Ga. The researchers examined, in detail, five patients with ICL. The studies involved serologic testing, culture, and polymerase chain reaction for the human immunodeficiency virus (HIV) types 1 and 2, serologic testing for the human T-cell lymphotropic virus (HTLV) types I and II, lymphocyte-transformation assays, as well as attempts to isolate a retroviral agent. The findings were compared with those in HIV-positive persons matched for CD4+ T-cell counts and with those in normal controls. The spouses of patients and the blood donors for one patients were also investigated. There was no evidence of HIV or HTLV infection in any of the five patients. All the patients had both low percentages and low counts of T-cells with relative increases in percentages, but not counts of CD8 cells. The patients had lower percentages and counts ofJCD8 cells and more lymphopenia than HIV positive patients. CD4 counts were relatively stable over time. Instead of the high immunoglobulin levels seen in HIV infection, these patients had normal or slightly low levels of immunoglobulins. The lymphocyte-transformation response to mitogens and antigens was depressed. ICL differs from HIV infection in its immunologic characteristics and in its apparent lack of progression over time. After researching the blood donors and family members of the patients, the researchers conclude that ICL is not transmissible. NOTE: Compilation by Michael Tidmus : AIDSwire. All rights reserved. Permission is granted to republish on electronic media for which no fee is charged, provided the complete text of this notice is attached to any republished portion or portions. * From the AIDS Daily Summary. The Centers for Disease Control and Prevention (CDC) National AIDS Clearinghouse has made this information available as a public service only. Providing this information does not constitute endorsement by the CDC, the CDC Clearinghouse, or any other organization. Reproduction of this text is encouraged; however, copies may not be sold. Copyright 1992, Information, Inc., Bethesda, MD. -----===[[[ A I D S w i r e D I G E S T 02.15.93 ]]]===----- .